Research Topics
| Anna Lena LopezSummaryAffiliation: International Vaccine Institute Publications
| Collaborators
|
Detail Information
Publications
Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adultsDang Duc Anh
National Institute of Hygiene and Epidemiology, Hanoi, Vietnam
Vaccine 25:1149-55. 2007..We found that this reformulated oral killed whole-cell cholera vaccine was safe, well tolerated and highly immunogenic...- Cholera vaccines for the developing worldAnna Lena Lopez
International Vaccine Institute, Seoul, Korea
Hum Vaccin 4:165-9. 2008..We review oral cholera vaccines that are currently available and in the pipeline including the need for policies that will ensure more extensive usage of these vaccines... 
The global burden of choleraMohammad Ali
International Vaccine Institute, SNU Research Park, Seoul, Republic of Korea
Bull World Health Organ 90:209-218A. 2012..To estimate the global burden of cholera using population-based incidence data and reports...- Community participation in two vaccination trials in slums of Kolkata, India: a multi-level analysisMohammad Ali
International Vaccine Institute, Seoul, Korea
J Health Popul Nutr 28:450-7. 2010..The results illustrated that participation in the trial was mostly influenced by various individual and community-level factors, which need to be addressed for a successful vaccination campaign... - Safety of the recombinant cholera toxin B subunit, killed whole-cell (rBS-WC) oral cholera vaccine in pregnancyRamadhan Hashim
International Vaccine Institute, Seoul, Korea
PLoS Negl Trop Dis 6:e1743. 2012..Balancing this concern is the known higher risk of cholera and of complications of pregnancy should cholera occur in these women, as well as the lack of expected adverse events from a killed oral bacterial vaccine... - The high burden of cholera in children: comparison of incidence from endemic areas in Asia and AfricaJacqueline L Deen
International Vaccine Institute, Seoul, Korea
PLoS Negl Trop Dis 2:e173. 2008..Cholera remains an important public health problem. Yet there are few reliable population-based estimates of laboratory-confirmed cholera incidence in endemic areas around the world... - Cholera outbreaks caused by an altered Vibrio cholerae O1 El Tor biotype strain producing classical cholera toxin B in Vietnam in 2007 to 2008Binh Minh Nguyen
National Institute of Hygiene and Epidemiology, Hanoi, Vietnam
J Clin Microbiol 47:1568-71. 2009.... - Paperless registration during survey enumerations and large oral cholera mass vaccination in Zanzibar, the United Republic of TanzaniaMohammad Ali
International Vaccine Institute, Kwanak PO Box 14, Seoul, 151 600, Republic of Korea
Bull World Health Organ 88:556-9. 2010..Field trials require extensive data preparation and complex logistics. The use of personal digital assistants (PDAs) can bypass many of the traditional steps that are necessary in a paper-based data entry system... - Vaccine Protection of Bangladeshi infants and young children against cholera: implications for vaccine deployment and person-to-person transmissionMohammad Ali
International Vaccine Institute, Seoul, Korea
Pediatr Infect Dis J 27:33-7. 2008..We investigated whether mass immunization of older children and adults can confer herd protection to children too young to be vaccinated... - A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, IndiaDilip Mahalanabis
Society for Applied Studies, Kolkata, India
PLoS ONE 3:e2323. 2008..This vaccine was reformulated to meet WHO requirements. We assessed the safety and immunogenicity of the reformulated bivalent (Vibrio cholerae 01 and 0139) killed whole cell oral vaccine in a cholera endemic area in Kolkata, India...